1,268
Views
30
CrossRef citations to date
0
Altmetric
Review Article

Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: A review

, , &
Pages 8-17 | Received 12 Sep 2013, Accepted 18 Oct 2013, Published online: 16 Dec 2013

References

  • Wongcharatrawee S, Groszmann RJ. Diagnosing portal hypertension. Baillieres Best Pract Res Clin Gastroenterol. 2000;14:881–94.
  • Zardi EM, Dobrina A, Ambrosino G, Margiotta D, Polistina F, Afeltra A. New therapeutic approaches to liver fibrosis: a practicable route?Curr Med Chem. 2008;15:1628–44.
  • Zardi EM, Navarini L, Sambataro G, Piccinni P, Sambataro FM, Spina C, et al. Hepatic PPARs: their role in liver physiology, fibrosis and treatment. Curr Med Chem. 2013;20:3370–96.
  • Shah V, Toruner M, Haddad F, Cadelina G, Papapetropoulos A, Choo K, et al. Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology. 1999;117:1222–8.
  • Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications. Gastroenterology. 2008;134:1715–28.
  • Bosch J, Pizcueta P, Feu F, Fernandez M, Garcia-Pagan JC. Pathophysiology of portal hypertension. Gastroenterol Clin North Am. 1992;21:1–13.
  • Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1). N Engl J Med. 1988;19:1065–72.
  • Schrier RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2). N Engl J Med. 1988;19:1127–34.
  • Møller S, Henriksen JH, Bendtsen F. Ascites: pathogenesis and therapeutic principles. Scand J Gastroenterol. 2009;44:902–11.
  • D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995;22:332–54.
  • D’Amico G, Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol. 1997;11:243–56.
  • De Franchis R. Portal hypertension. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies. Oxford, UK: Blackwell Science;2001. p. 36–64.
  • Ripoll C. Hepatic venous pressure gradient and outcomes in cirrhosis. J Clin Gastroenterol. 2007;41:S330–5.
  • Parikh S. Hepatic venous pressure gradient: worth another look?. Dig Dis Sci. 2009;54:1178–83.
  • Bosch J, Abraldes JG, Berzigotti A, Garcia-Pagan JC. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6:573–82.
  • Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280–90.
  • Kumar A, Sharma P, Sarin SK. Hepatic venous pressure gradient measurement: time to learn. Indian J Gastroenterol. 2008;27:74–80.
  • Moitinho E, Escorsell A, Bandi JC, Salmerón JM, García-Pagán JC, Rodés J, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626–31.
  • Ripoll C, Bañares R, Rincón D, Catalina MV, Lo Iacono O, Salcedo M, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD era. Hepatology. 2005;42:793–801.
  • Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 1995;346:1056–9.
  • Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Bellini B, Bighin R, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930–4.
  • Bureau C, Péron JM, Alric L, Morales J, Sanchez J, Barange K, et al. A la carte treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology. 2002;36:1361–6.
  • Sanyal AJ, Genning C, Reddy KR, Wong F, Kowdley KV, Benner K, et al. The North American Study for the Treatment of Refractory Ascites. Gastroenterology. 2003;124:634–41.
  • Blasco A, Forns X, Carrión JA, García-Pagán JC, Gilabert R, Rimola A, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006;43:492–9.
  • Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, et al. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria. J Hepatol. 2010;52:45–53.
  • Merkel C, Montagnese S. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding?Yes! Eur J Intern Med. 2011;22:1–4.
  • Wadhawan M, Dubey S, Sharma BC, Sarin SK. Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci. 2006;51:2264–9.
  • Castéra L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol. 2008;48:835–47.
  • Piscaglia F, Marinelli S, Bota S, Serra C, Venerandi L, Leoni S, et al. The role of ultrasound elastographic techniques in chronic liver disease: current status and future perspectives. Eur J Radiol. 2013 Jul 23. [Epub ahead of print]
  • Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.
  • Foucher J, Chanteloup E, Vergniol J, Castéra L, Le Bail B, Adhoute X, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–8.
  • Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–50.
  • Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, et al. Comparison of liver biopsy and transient elastography based on clinical relevance. Can J Gastroenterol. 2008;22:753–7.
  • Bosch J. Predictions from a hard liver. J Hepatol. 2006;45:174–7.
  • Vizzutti F, Arena U, Rega L, Pinzani M. Non invasive diagnosis of portal hypertension in cirrhotic patients. Gastroenterol Clin Biol. 2008;32(6 Suppl 1):80–7.
  • Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33:62–71.
  • Gao J, Ran HT, Ye XP, Zheng YY, Zhang DZ, Wang ZG. The stiffness of the liver and spleen on ARFI Imaging pre and post TIPS placement: a preliminary observation. Clin Imaging. 2012;36:135–41.
  • Rifai K, Cornberg J, Bahr M, Mederacke I, Potthoff A, Wedemeyer H, et al. ARFI elastography of the spleen is inferior to liver elastography for the detection of portal hypertension. Ultraschall Med. 2011;32(Suppl 2):E24–30.
  • Bota S, Sporea I, Sirli R, Focsa M, Popescu A, Danila M, et al. Can ARFI elastography predict the presence of significant esophageal varices in newly diagnosed cirrhotic patients?Ann Hepatol. 2012;11:519–25.
  • Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Toshikuni N, et al. Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices. Gastroenterology. 2013;144:92–101.
  • Hirooka M, Ochi H, Koizumi Y, Kisaka Y, Abe M, Ikeda Y, et al. Splenic elasticity measured with real time tissue elastography is a marker of portal hypertension. Radiology. 2011;261:960–8.
  • de Franchis R. Evolving consensus in portal hypertension: report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005;43:167–76.
  • de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53:762–8.
  • Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, et al. A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol. 2010;105:1382–90.
  • Singal AK, Ahmad M, Soloway RD. Duplex Doppler ultrasound examination of the portal venous system: an emerging novel technique for the estimation of portal vein pressure. Dig Dis Sci. 2009;55:1230–40.
  • Cottone M, Sciarrino E, Marceno M, Maringhini A, D’Amico G, Traina M, et al. Ultrasound for the screening of patients with cirrhosis with large varices. Br Med J (Clin Res Ed). 1983;287:533.
  • Schepis F, Cammà C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection?Hepatology. 2001;33:333–8.
  • Berzigotti A, Gilabert R, Abraldes JG, Nicolau C, Bru C, Bosch J, et al. Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis. Am J Gastroenterol. 2008;103:1159–67.
  • Zardi EM, Uwechie V, Gentilucci UV, Dobrina A, Petitti T, Laghi V, et al. Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role?Ultrasound Med Biol. 2007;33:506–11.
  • Zardi EM, Uwechie V, Caccavo D, Pellegrino NM, Cacciapaglia F, Di Matteo F, et al. Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance. J Gastroenterol. 2009;44:76–83.
  • Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 1992;16:298–303.
  • Kayacetin E, Efe D, Doğan C. Portal and splenic hemodynamics in cirrhotic patients: relationship between esophageal variceal bleeding and the severity of hepatic failure. J Gastroenterol. 2004;39:661–7.
  • Li FH, Hao J, Xia JG, Li H-L, Fang H. Hemodynamic analysis of esophageal varices in patients with liver cirrhosis using color Doppler ultrasound. World J Gastroenterol. 2005;11:4560–5.
  • Baik SK. Haemodynamic evaluation by Doppler ultrasonography in patients with portal hypertension: a review. Liver International. 2010;30:1403–13.
  • Nelson RC, Sherbourne GM, Spencer HB, Chezmar J. Splenic venous flow exceeding portal venous flow at Doppler sonography: relationship to portosystemic varices. Am J Roentgenol. 1993;161:563–7.
  • Baik SK, Kim JW, Kim HS, Kwon SO, Kim YJ, Park JW, et al. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response. Radiology. 2006;240:574–80.
  • Dökmeci AK, Kimura K, Matsutani S, Ohto M, Ono T, Tsuchiya Y, et al. Collateral veins in portal hypertension: demonstration by sonography. Am J Roentgenol. 1981;137:1173–7.
  • Matsutani S, Furuse J, Ishii H, Mizumoto H, Kimura K, Ohto M. Hemodynamics of the left gastric vein in portal hypertension. Gastroenterology. 1993;105:513–18.
  • Berzigotti A, Merkel C, Magalotti D, Tiani C, Gaiani S, Sacerdoti D, et al. New abdominal collaterals at ultrasound: a clue of progression of portal hypertension. Dig Liver Dis. 2008;40:62–7.
  • Nakano R, Iwao T, Oho K, Toyonaga A, Tanikawa K. Splanchnic hemodynamic pattern and liver function in patients with cirrhosis and esophageal or gastric varices. Am J Gastroenterol. 1997;92: 2085–9.
  • Maruyama H, Ishihara T, Ishii H, Tsuyuguchi T, Yoshikawa M, Matsutani S, et al. Blood flow parameters in the short gastric vein and splenic vein on Doppler ultrasound reflect gastric variceal bleeding. Eur J Radiol. 2010;75:e41–5.
  • Gupta D, Chawla YK, Dhiman RK, Suri S, Dilawari JB. Clinical significance of patent paraumbilical vein in patients with liver cirrhosis. Dig Dis Sci. 2000;45:1861–4.
  • Morin C, Lafortune M, Pomier G, Robin M, Breton G. Patent paraumbilical vein: anatomic and hemodynamic variants and their clinical importance. Radiology. 1992;185:253–6.
  • Tarzamni MK, Somi MH, Farhang S, Jalivand M. Portal haemodynamics as predictors of high risk esophageal varices in cirrhotic patients. World J Gastroenterol. 2008;14:1898–902.
  • Moriyasu F, Nishida O, Ban N, Nakamura T, Sakai M, Miyake T, et al.“Congestion index” of the portal vein. AJR Am J Roentgenol. 1986;146:735–9.
  • Merkel C, Sacerdoti D, Bolognesi M, Bombonato G, Gatta M. Doppler sonography and hepatic vein catheterization in portal hypertension: assessment of agreement in evaluating severity and response to treatment. J Hepatol. 1998;28:622–30.
  • Vizzutti F, Arena U, Rega L, Romanelli RG, Colagrande S, Cuofano S, et al. Performance of Doppler ultrasound in the prediction of sever portal hypertension in hepatitis C virus-related chronic liver disease. Liver Int. 2007;27:1379–88.
  • Liu CH, Hsu SJ, Liang CC, Tsai FC, Lin JW, Liu CJ, et al. Esophageal varices: noninvasive diagnosis with duplex Doppler US in patients with compensated cirrhosis. Radiology. 2008;248:132–9.
  • Yin XY, Lu MD, Huang JF, Xie XY, Liang LJ. Color Doppler velocity profile assessment of portal hemodynamics in cirrhotic patients with portal hypertension: correlation with esophageal variceal bleeding. J Clin Ultrasound. 2001;29:7–13.
  • Iwao T, Toyonaga A, Oho K, Tayama C, Masumoto H, Sakai T, et al. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol. 1997;92:1012–17.
  • Piscaglia F, Donati G, Serra C, Muratori R, Solmi L, Gaiani S, et al. Value of splanchnic Doppler ultrasound in the diagnosis of portal hypertension. Ultrasound Med Biol. 2001;27:893–9.
  • Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Gatta A. Non-invasive grading of the severity of portal hypertension in cirrhotic patients by echo color Doppler. Ultrasound Med Biol. 2001; 27:901–7.
  • Kim MY, Suk KT, Baik SK, Kim HA, Kim YJ, Cha SH, et al. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology. 2012;56:1053–62.
  • Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2003;19:250–8.
  • Grace ND, Groszmann RJ, Garcia-Tsao G, Burroughs AK, Pagliaro L, Makuch RW, et al. Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology. 1998;28:868–80.
  • Dagher L, Burroughs A. Variceal bleeding and portal hypertensive gastropathy. Eur J Gastroenterol. 2001;13:81–8.
  • Jensen DM. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology. 2002;122:1620–30.
  • Merkel C, Zoli M, Siringo S, van Buuren H, Magalotti D, Angeli P, et al. Prognostic indicators of risk for first variceal bleeding in cirrhosis: a multicenter study in 711 patients to validate and improve the North Italian Endoscopic Club (NIEC) index. Am J Gastroenterol. 2000;95: 2915–20.
  • Arndorfer RC, Stef JJ, Dodds WJ, Linchan JH, Hogan WJ. Improved infusion system for intraluminal esophageal manometry. Gastroenterology. 1977;73:23–7.
  • Schiano TD, Adrian AL, Cassidy MJ, McCray W, Liu JB, Baranowski RJ, et al. Use of high resolution endoluminal sonography to measure the radius and wall thickness of esophageal varices. Gastrointest Endosc. 1996;44:425–8.
  • Lee YT, Chan FK, Ching JY, Lai CW, Leung VK, Chung SC, et al. Diagnosis of gastroesophageal varices and portal collateral venous abnormalities by endosonography in cirrhotic patients. Endoscopy. 2002;34:391–8.
  • Jackson FW, Adrain AL, Black M, Miller LS. Calculation of esophageal variceal wall tension by direct sonographic and manometric measurements. Gastrointest Endosc. 1999;50:247–51.
  • Rigau J, Bosch J, Bordas JM, Navasa M, Mastai R, Kravetz D, et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96:873–80.
  • Miller LS, Dai Q, Thomas A, Chung CY, Park J, Irizarry S, et al. A new ultrasound-guided esophageal variceal pressure measuring device. Am J Gastroenterol. 2004;99:1267–73.
  • Miller L, Banson FL, Bazir K, Korimilli A, Liu JB, Dewan R, et al. Risk of esophageal variceal bleeding based on endoscopic ultrasound evaluation of the sum of esophageal variceal cross-sectional surface area. Am J Gastroenterol. 2003;98:454–9.
  • Vegesna AK, Chung CY, Bajaj A, Tiwana MI, Rishikesh R, Hamid I, et al. Minimally invasive measurement of esophageal variceal pressure and wall tension. Gastrointest Endosc. 2009;70:407–13.
  • Schiano TD, Adrain AL, Vega KJ, Liu JB, Black M, Miller LS. High-resolution endoluminal sonography assessment of the hematocystic spots of esophageal varices. Gastrointest Endosc. 1999;49: 424–7.
  • Wu MT, Pan HB, Chen C, Chang JM, Lo GH, Wu SS, et al. Azygos blood flow in cirrhosis: measurement with MR imaging and correlation with variceal hemorrhage. Radiology. 1996;198:457–62.
  • Kassem AM, Salama ZA, Zakaria MS, Hassaballah M, Hunter MS. Endoscopic ultrasonographic study of the azygos vein before and after endoscopic obliteration of esophagogastric varices by injection sclerotherapy. Endoscopy. 2000;32:630–4.
  • Leung VK, Sung JJ, Ahuja AT, Tumala IE, Lee YT, Lau JY, et al. Large paraesophageal varices on endosonography predict recurrence of esophageal varices and rebleeding. Gastroenterology. 1997;112: 1811–16.
  • Sato T, Yamazaki K, Toyota J, Karino Y, Ohmura T, Akaike J. Observation of gastric variceal flow characteristics by endoscopic ultrasonography using color Doppler. Am J Gastroenterol. 2008;103:575–80.
  • Yin M, Chen J, Glaser KJ, Talwalkar JA, Ehman RL. Abdominal magnetic resonance elastography. Top Magn Reson Imaging. 2009;20: 79–87.
  • Yin M, Talwalkar JA, Glaser KJ, Manduca A, Grimm RC, Rossman PJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5:1207–13.
  • Salameh N, Peeters F, Sinkus R, Abarca-Quinones J, Annet L, Ter Beek LC, et al. Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging. 2007;26:956–62.
  • Talwalkar JA, Yin M, Venkatesh S, Rossman PJ, Grimm RC, Manduca A, et al. Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension. AJR Am J Roentgenol. 2009;193:122–7.
  • Nedredal GI, Yin M, McKenzie T, Lillegard J, Luebke-Wheeler J, Talwalkar J, et al. Portal hypertension correlates with splenic stiffness as measured with MR elastography. J Magn Reson Imaging. 2011;34: 79–87.
  • Yin M, Talwalkar JA, Glaser KJ, Venkatesh SK, Chen J, Manduca A, et al. Dynamic postprandial hepatic stiffness augmentation assessed with MR elastography in patients with chronic liver disease. AJR Am J Roentgenol. 2011;197:64–70.
  • Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7:141–55.
  • Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, Valla DC, et al. Relationship between the Fibrotest and portal hypertension in patients with liver disease. Aliment Pharmacol Ther. 2007;26:359–68.
  • Eslam M, Ampuero J, Jover M, Abd-Elhalim H, Rincon D, Shatat M, et al. Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables. Ann Hepatol. 2013; 12:588–98.
  • Zaman A, Hapke R, Flora K, Rosen HR, Benner K. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94:3292–6.
  • Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, García-Pagán JC, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013;144:102–11.
  • Moodley J, Lopez R, Carey W. Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8:703–8.
  • Schlansky B, Lee B, Hartwell L, Urquhart J, Willis B, Zaman A. Guideline adherence and outcomes in esophageal variceal hemorrhage: comparison of tertiary care and non-tertiary care settings. J Clin Gastroenterol. 2012;46:235–42.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.